Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Ambix Laboratories

This article was originally published in The Tan Sheet

Executive Summary

Ambix Laboratories: Blue Gel pediculicide subject of Dec. 30 warning letter from FDA stating that the product is "misbranded" because it lacks directions and warnings required under the pediculicide final rule and does not declare the USP-established name of "pyrethrum extract." East Rutherford, N.J.-based Ambix, maker of Rx and OTC private label creams, gels and liquids, has issued several product recalls in past years and was subject to a 1993 seizure of OTC hydrocortizone cream for contamination with Staphylococcus aureus bacteria and concurrent regulatory action for noncompliance with Good Manufacturing Practices ("The Tan Sheet" Aug. 2, 1993, p. 15)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel